使用基于MAPK和NFκB通路的分子对接选潜在的抗骨关节炎化合物,并验证它们的抗骨关节炎作用
Tian-Wang Zhu1, Yu Zheng2, Rui-Xin Li1
1Department of Sports Medicine, Dalian University Affiliated Xinhua Hospital, Dalian, Liaoning, China.
PloS one
|March 25, 2025
概括
分子对接通过准MAPK和NFκB通路,有效选潜在的骨关节炎治疗方法. 几种化合物在细胞研究中显示出有前途的抗关节炎作用,需要进一步调查.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 骨关节炎 (OA) 是一种常见的退行性关节疾病,具有有限的非手术治疗选择.
- 分子对接是药物发现中的一个有价值的工具,但其在选OA特异性化合物中的应用尚未得到充分探索.
研究的目的:
- 使用分子对接准MAPK和NFκB途径选潜在的抗关节炎化合物.
- 为了在体外验证所选化合物的抗关节炎作用.
主要方法:
- 对51种化合物进行了分子对接,这些化合物针对MAPK和NFκB通路中的核心人类蛋白质.
- 分析了对接化合物的药物相似性,药理动力学,生物活性和毒性.
- 评估了精选化合物的细胞毒性和抗骨关节炎作用,对小鼠的肌肉细胞.
主要成果:
- 确定了科里拉金,阿比格特林,普罗托平,5-甲基黄和7,3',4'-三氧黄作为潜在的候选药物.
- 在ERK2,JNK2和p38蛋白中,这些化合物具有共同的结合点.
- 在体外研究证实了Protopine,5-甲基和7,3',4'-三基的抗关节炎潜力.
结论:
- 基于途径的分子对接是发现新型抗骨关节炎药物的可行策略.
- 普罗托平,5-甲基黄和7,3',4'-三氧黄显示出进一步OA药物开发的巨大潜力.
- 未来的研究应该集中在这些有前途的化合物的体内验证和机制阐明上.
更多相关视频
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
478
07:06Destabilization of the Medial Meniscus and Cartilage Scratch Murine Model of Accelerated Osteoarthritis
Published on: July 6, 2022
4.2K
相关概念视频
01:07MAPK Signaling Cascades
5.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.0K
01:20The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
02:26NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K